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Background: Intrauterine environment plays a pivotal role in the origin of fatal diseases such as the metabolic
syndrome. Diabetes is associated with low-grade inflammatory state and dysregulated adipokines production. The
aim of this study is to investigate the effect of maternal diabetes on adipocytokines (adiponectin, leptin and TNF-α)
production in F1 offspring in rats.
Methods: The offspring groups were as follows: F1 offspring of control mothers under control diet (CD) (CF1-CD),
F1 offspring of control mothers under high caloric diet (HCD) (CF1-HCD), F1 offspring of diabetic mothers under
CD (DF1-CD), and F1 offspring of diabetic mothers under HCD (DF1-HCD). Every 5 weeks post-natal, 10 pups of
each subgroup were culled to obtain blood samples for biochemical analysis.
Results: The results indicate that DF1-CD and DF1-HCD groups exhibited hyperinsulinemia, dyslipidemia, insulin
resistance and impaired glucose homeostasis compared to CF1-CD (p > 0.05). DF1-CD and DF1-HCD groups had high
hepatic and muscular depositions of TGs. The significant elevated NEFA level only appeared in offspring of diabetic
mothers that was fed HCD. DF1-CD and DF1-HCD groups demonstrated low serum levels of adiponectin, high levels of
leptin, and elevated levels of TNF-α compared to CF1-CD (p > 0.05). These results reveal the disturbed metabolic lipid
profile of offspring of diabetic mothers and could guide further characterization of the mechanisms involved.
Conclusion: Dysregulated adipocytokines production could be a possible mechanism for the transgenerational
transmittance of diabetes, especially following a postnatal diabetogenic environment. Moreover, the exacerbating
effects of postnatal HCD on NEFA in rats might be prone to adipcytokine dysregulation. Furthermore, dysregulation of
serum adipokines is a prevalent consequence of maternal diabetes and could guide further investigations to predict
the development of metabolic disturbances.
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There is a compelling clinical and epidemiological
evidence suggests that prenatal environment plays a
pivotal role in the origin of fatal diseases such as the
metabolic syndrome and its components: hypertension,
insulin resistance, and dyslipidemia [1]. The altered
maternal metabolism in diabetic mothers appears to be
associated with a diabetogenic effect in the adult
offspring, through adaptations during intrauterine fetal* Correspondence: m.ibrahim1988@hotmail.com
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occur at the gene, cellular, tissue, organ, and system
levels, culminating in long-lasting structural and func-
tional changes [3].
Adiponectin have insulin-sensitizing, anti-diabetic, anti-
oxidant, anti-inflammatory and anti-atherogenic proper-
ties through its action on adiponectin receptors, e.g.,
AdipoR1 and AdipoR2 [4]. Leptin is an adipokines
involved in the pathogenesis of obesity, insulin resist-
ance, inflammation, and diabetes. It has a regulatory
action on satiety and energy homeostasis, production
of inflammatory mediators, and on lipid and carbohy-
drate metabolism [4]. Diabetes is associated withle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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leptin. This reflects a state of adiponectin deficiency and
leptin resistance, which could be a possible mechanism
for development of diabetes complications [4–6].
Low-grade inflammation is a hallmark of type 2 diabetes
and metabolic syndrome [4]. Tumor necrosis factor-α
(TNF-α) is an inflammatory cytokine that has a myriad of
functions such as mediating apoptosis and regulation of
immune system. TNF-α exerts its effects among various
cells via its action on its TNFR1 and TNFR2 receptors [4].
Serum TNF-α level is elevated in type 1 and type 2 dia-
betic patients and is correlated with various complications
of diabetes [7, 8].
Intrauterine epigenetic modifications, deterioration of
glucose tolerance and oxidative stress could be a possible
mechanisms for the transgenerational transmittance ofTable 1 Hepatic and muscular content of TGs (mg/g tissue) in diffe
Age (Weeks) Sex CF1-CD C
Hepatic TGs content (mg/g tissue)
5 Male 76.4 ± 7 7
Female 74 ± 6 7
10 Male 81 ± 8 8
Female 78 ± 5 8
15 Male 84 ± 7 9
Female 81 ± 5 8
20 Male 86 ± 8 9
Female 83 ± 6 8
25 Male 94 ± 9 9
Female 87 ± 6 9
30 Male 98 ± 9 1
Female 92 ± 7 9
Muscular TGs content (mg/g tissue)
5 Male 1.52 ± 0.12 1
Female 1.44 ± 0.11 1
10 Male 1.75 ± 0.1 1
Female 1.63 ± 0.13*** 1
15 Male 1.82 ± 0.12 2
Female 1.71 ± 0.1*** 1
20 Male 2 ± 0.11 2
Female 1.86 ± 0.14*** 1
25 Male 2.1 ± 0.12 2
Female 1.94 ± 0.13*** 2
30 Male 1.9 ± 0.1 2
Female 1.85 ± 0.12 1
Data are presented as mean ± SD (n = 10)
Abbreviations denote: CF1-CD; F1 offspring of control mothers under control diet, C
diabetic mothers under control diet, and DF1-HCD; F1 offspring of diabetic mothers
*Significant Different from CF1-CD by ANOVA (p < 0.05)
**Significant Different from CF-HCD by ANOVA (p < 0.05)
***Significant different from male at each age by t-test (p < 0.05)diabetes [9, 10]; however, the exact mechanism is
not fully understood. Therefore, the aim of this
study is to investigate the effect of maternal diabetes
on adipocytokines (adiponectin, leptin and TNF-α)
production in F1 offspring in rats, as a potential
mechanism for the transgenerational effect of mater-
nal diabetes.Methods
Animals
The study was done in accordance with the ethical
guidelines of the Medical Research Institute, Alexandria
University, Egypt. Wistar rats were housed 4 per cage at
an ambient temperature of 23 ± 1 °C with 12/12 h light/
dark cycles and 45 ± 5% humidity.rent study groups
F1-HCD DF1-CD DF1-HCD
8 ± 8 77 ± 6 79 ± 6
6 ± 5 75 ± 5 76 ± 5
5 ± 8 87 ± 7 91 ± 8*
0 ± 6 81 ± 5*** 85 ± 7*
2 ± 9* 96 ± 8* 105 ± 9*,**
4 ± 7*** 86 ± 7*** 92 ± 7*,**,***
4 ± 8* 98 ± 6* 109 ± 9*,**
8 ± 6 92 ± 7* 99 ± 10*,**,***
9 ± 9 103 ± 9* 111 ± 10*,**
4 ± 7 98 ± 6* 104 ± 8*,**
04 ± 10 108 ± 9* 116 ± 10*,**
6 ± 8 102 ± 8* 110 ± 9*,**
.53 ± 0.1 1.6 ± 0.11 1.65 ± 0.13*,**
.5 ± 0.11 1.48 ± 0.12*** 1.51 ± 0.12***
.9 ± 0.14* 1.84 ± 0.14 2.25 ± 0.17*,**
.82 ± 0.13* 1.71 ± 0.13*** 1.88 ± 0.12*,***
.1 ± 0.12* 2.05 ± 0.16* 2.74 ± 0.21*,**
.85 ± 0.12*,*** 1.89 ± 0.17*,*** 2.2 ± 0.16*,**,***
.15 ± 0.14* 2.20 ± 0.15* 2.81 ± 0.17*,**
.94 ± 0.13*** 2.04 ± 0.17*,*** 2.32 ± 0.21*,**,***
.2 ± 0.15 2.48 ± 0.2*,** 2.96 ± 0.23*,**
.1 ± 0.12* 2.2 ± 0.16*,*** 2.46 ± 0.21*,**,***
.2 ± 0.15* 2.7 ± 0.15*,** 3 ± 0.26*,**
.98 ± 0.11*** 2.55 ± 0.18*,** 2.78 ± 0.19*,**,***
F1-HCD; F1 offspring of control mothers under HCD, DF1-CD; F1 offspring of
under HCD
Table 2 Serum NEFA level (mmol/ml) in different study groups
Age (Weeks) Sex CF1-CD CF1-HCD DF1-CD DF1-HCD
5 Male 1.1 ± 0.10 1.21 ± 0.14 1.1 ± 0.10 1.22 ± 0.10*
Female 1.2 ± 0.16 1.28 ± 0.12 1.25 ± 0.17*** 1.31 ± 0.20
10 Male 1.15 ± 0.12 1.32 ± 0.14* 1.2 ± 0.10 1.37 ± 0.14*
Female 1.23 ± 0.12 1.38 ± 0.17* 1.26 ± 0.15 1.41 ± 0.14*
15 Male 1.20 ± 0.15 1.38 ± 0.13 1.25 ± 0.14 1.41 ± 0.12*
Female 1.31 ± 0.18 1.43 ± 0.12 1.33 ± 0.14 1.46 ± 0.12*
20 Male 1.20 ± 0.11 1.42 ± 0.12* 1.25 ± 0.12 1.5 ± 0.10*
Female 1.33 ± 0.12 1.47 ± 0.13* 1.35 ± 0.12 1.5 ± 0.16*
25 Male 1.18 ± 0.13 1.49 ± 0.14* 1.29 ± 0.14 1.54 ± 0.12*
Female 1.39 ± 0.14*** 1.5 ± 0.12 1.42 ± 0.14 1.54 ± 0.17*
30 Male 1.20 ± 0.15 1.52 ± 0.15* 1.3 ± 0.15 1.6 ± 0.14*
Female 1.4 ± 0.20*** 1.5 ± 0.15 1.44 ± 0.20 1.63 ± 0.17*
Data are presented as mean ± SD (n = 10)
Abbreviations denote: CF1-CD; F1 offspring of control mothers under control diet, CF1-HCD; F1 offspring of control mothers under HCD, DF1-CD; F1 offspring of
diabetic mothers under control diet, and DF1-HCD; F1 offspring of diabetic mothers under HCD
*Significant different from CF1-CD by ANOVA (p < 0.05)
***Significant different from male at each age by t-test (p < 0.05)
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Female rats were allocated randomly in two groups:
control and diabetic. Diabetes was instigated via neo-
natal injection of streptozotocin (100 mg/kg) at the day
5 postnatally. After 12 weeks, chronic hyperglycemia
was confirmed; where rats exhibited fasting blood glu-
cose (FBG) level >200 mg/dl were considered diabetic.
78 hyperglycemic female rats were obtained and main-
tained under normal control diet (CD) throughout the
experiment.
Pregnancy was established by overnight mating the
females (control and diabetic) with normal healthy
males. Pregnancy was confirmed next morning by the
presence of vaginal mucus plug. Pregnancies were
completed to term. After delivery, the offspring were
weaned to control diet (CD) or high-caloric diet
(HCD) and followed up for 30 weeks. Therefore, the
offspring groups were as follows: F1 offspring of
control mothers under CD (CF1-CD), F1 offspring of
control mothers under HCD (CF1-HCD), F1 offspring
of diabetic mothers under CD (DF1-CD), and F1 off-
spring of diabetic mothers under HCD (DF1-HCD).
Pregnancy outcome and composition of diets used
were previously published [11]. Every 5 weeks post-
natal, 10 pups of each subgroup were culled after
overnight fasting to obtain blood samples for bio-
chemical analysis.Biochemical analysis
FBG level was measured using Glucometer (One Touch,
Johnson and Johnson Co.). Lipid profile was assessed byusing a commercial diagnostic kit (Randox (UK)) according
to the manufacturer instructions.
ELISA measurements
Plasma insulin was assayed using ELISA kit (Mercodia).
Serum levels of adiponectin, leptin, NEFA and TNF-α
were assessed using ELISA kits (Chemicon, RayBio,
MyBioSource and R&D Systems respectively) according
to the manufacturer instructions.
Statistical analysis
All statistical analyses were performed using SPSS statistical
software version 18 (SPSS, Chicago, IL). The data were ana-
lyzed using the one-way analysis of variance (ANOVA)
followed by LSD test to compare the mean values from the
offspring of diabetic mothers and the offspring of control
mothers. t test was employed to compare the mean values
of females and those of males of the same group at the
same age. The results are presented as mean ± SEM or
mean ± SD and values of p > 0.05 were considered non-




Fasting Blood Glucose (FBG) level
At week 5, only males of DF1-HCD showed significantly
higher FBG than CF1-CD group. At week 30, males and
females of DF1-HCD exhibited significantly higher FBG
than CF1-CD group. Furthermore, males of DF1-HCD
had significantly higher FBG than females of the same
group at the 30th week (Fig. 1).
Table 3 Serum levels of cytokines in different study groups
Age (Weeks) Sex CF1-CD CF1-HCD DF1-CD DF1-HCD
Adiponectin (ng/ml)
5 Male 12.8 ± 1.2 12.5 ± 1.3 12.4 ± 1.5 12.1 ± 1.1
Female 17.9 ± 1.5*** 16.9 ± 1.6*** 17.0 ± 1.6*** 16.8 ± 1.8***
10 Male 13.2 ± 0.9 13 ± 1.2 12.0 ± 1.3* 11.4 ± 1.2*,**
Female 17.6 ± 1.4*** 16.5 ± 1.5*** 16.7 ± 1.5 16.2 ± 1.7***
15 Male 13.6 ± 1.4 13.1 ± 1.2 12.0 ± 1.4 11.2 ± 1.1*,**
Female 17.1 ± 1.5*** 16.4 ± 1.2*** 16.5 ± 1.6*** 16.3 ± 1.5***
20 Male 14 ± 1.1 12.6 ± 1.32* 11.8 ± 1.2* 9.8 ± 1*,**
Female 16.8 ± 1.6*** 16.5 ± 1.5*** 16.1 ± 2*** 15.6 ± 2***
25 Male 14.2 ± 1.3 12.4 ± 1.3* 10.5 ± 1.4*,** 9.3 ± 1.2*,**
Female 16.7 ± 2*** 16.6 ± 2*** 15.6 ± 1.8*** 14.9 ± 2*,**
30 Male 14.8 ± 1.2 12.5 ± 1.2* 10.0 ± 1.3*,** 9.2 ± 1.1*,**
Female 16.6 ± 1.9*** 16.4 ± 1.9*** 15.4 ± 2*** 14.2 ± 1.9*,**,***
Leptin (ng/ml)
5 Male 0.54 ± 0.08 0.56 ± 0.07 0.62 ± 0.11* 0.62 ± 0.1*
Female 1.6 ± 0.1*** 1.64 ± 0.12*** 1.71 ± 0.08***,** 1.68 ± 0.11**
10 Male 0.3 ± 0.09 0.44 ± 0.09* 0.38 ± 0.12* 0.46 ± 0.1*
Female 1.1 ± 0.09*** 1.18 ± 0.14*** 1.3 ± 0.07*,**,*** 1.43 ± 0.12*,**,***
15 Male 0.26 ± 0.08 0.43 ± 0.11* 0.34 ± 0.09*,** 0.45 ± 0.14*
Female 0.94 ± 0.08*** 0.96 ± 0.1*** 1.04 ± 0.11*** 1.22 ± 0.08*,**,***
20 Male 0.24 ± 0.11 0.41 ± 0.09* 0.330.08*,** 0.44 ± 0.12*
Female 0.81 ± 0.11*** 0.9 ± 0.06*** 0.95 ± 0.09*,*** 1.3 ± 0.11*,**,***
25 Male 0.22 ± 0.09 0.4 ± 0.11* 0.31 ± 0.1*,** 0.45 ± 0.14*
Female 0.84 ± 0.12*** 0.91 ± 0.14*** 0.97 ± 0.12*,*** 1.34 ± 0.1*,**,***
30 Male 0.19 ± 0.09 0.41 ± 0.11* 0.3 ± 0.05*,** 0.42 ± 0.15*
Female 0.9 ± 0.1*** 0.95 ± 0.1*** 0.97 ± 0.15*** 1.36 ± 0.12*,**,***
TNF-α (pg/ml)
5 Male 17 ± 2.1 23 ± 2.1* 26 ± 2.4*,** 29 ± 2.3*,**
Female 23 ± 3*** 24 ± 2.5 24 ± 2.7 26 ± 3*,***
10 Male 19 ± 2.3 22 ± 2.4* 37 ± 2.3*,** 46 ± 4*,**
Female 25 ± 3*** 26 ± 2.6*** 31 ± 3.4*,**,*** 29 ± 5*,**,***
15 Male 19 ± 2 23 ± 2* 42 ± 2.6*,** 55 ± 5.3*,**
Female 27 ± 4*** 31 ± 3*,*** 33 ± 3.1*,*** 34 ± 5*,***
20 Male 20 ± 2.4 25 ± 2.4* 52 ± 2*,** 61 ± 6*,**
Female 29 ± 3*** 33 ± 2.5*,*** 32 ± 3*** 36 ± 5*,***
25 Male 21 ± 2.1 27 ± 2.1* 60 ± 2.3*,** 66 ± 7*,**
Female 30 ± 2*** 34 ± 3*,*** 33 ± 4*** 41 ± 6*,**,***
30 Male 22 ± 1.8 31 ± 2.2* 71 ± 2.1*,** 74 ± 7.8*,**
Female 32 ± 3*** 35 ± 3*** 35 ± 3.8*** 44 ± 7*,**,***
Data are presented as mean ± SD (n = 10)
Abbreviations denote: CF1-CD; F1 offspring of control mothers under control diet, CF1-HCD; F1 offspring of control mothers under HCD, DF1-CD; F1 offspring of
diabetic mothers under control diet, and DF1-HCD; F1 offspring of diabetic mothers under HCD
*Significant different from CF1-CD by ANOVA (p < 0.05)
**Significant different from CF-HCD by ANOVA (p < 0.05)
***Significant different from male at each age by t-test (p < 0.05)
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Fig. 1 Glucose homeostasis parameters for all study groups at the 5th week (a, c and e) and the 30th week (b, d and f). Data are presented as
mean ± SEM (n = 10). Abbreviations denote: CF1-CD; F1 offspring of control mothers under CD, CF1-HCD; F1 offspring of control mothers under
HCD, DF1-CD; F1 offspring of diabetic mothers under CD, and DF1-HCD; F1 offspring of diabetic mothers under HCD. *Significant different
compared to the CF1-CD group by ANOVA (p < 0.05). #Significant different from the males of the same group at the same age by t test (p < 0.05)
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At week 5, males of both DF1-CD and DF1-HCD
groups and females of DF1-HCD group showed sig-
nificantly higher insulin levels than CF1-CD group.
Also, females of CF1-CD and CF1-HCD groups
showed higher insulin levels than their male counter-
parts (Fig. 1). At week 30, only females of CF1-HCD
group as well as all members of DF1-CD and DF1-
HCD groups exhibited significantly higher insulin
levels than CF1-CD group (Fig. 1).Homeostasis Model Assessment of Insulin Resistance
(HOMA-IR)
The insulin resistance index calculated by the HOMA
model (HOMA-IR) using fasting serum levels of insulin
(μIU/ml) and glucose levels (mmol/l) indicated that
males and females of DF1-HCD group were insulin
resistant compared to CF1-CD group (Fig. 1). At the
30th week, only females of CF1-HCD group as well as all
members of DF1-CD and DF1-HCD groups were insulin
resistant compared to CF1-CD group. Moreover, males
Tawfik et al. Journal of Animal Science and Technology  (2017) 59:1 Page 6 of 11of DF1-CD and DF1-HCD groups had higher HOMA-IR
levels than their female counterparts (Fig. 1).
Lipid profile
All diabetic groups showed significantly elevated serum
triglycerides (TGs) level compared to CF1-CD and CF1-
HCD groups throughout the 3 time points, except the
females of DF1-CD at the 5th week, when they showed
only significant difference with CF1-CD. Moreover, CF1-
HCD group exhibited a significant high TGs level
compared to CF1-CD at the 30th week (Fig. 2).
Members of CF1-HCD had a significant high NEFA
level from week 10 to week 30 compared to CF1-CD,
except the females at weeks 15, 25 and 30. All members
of DF1-HCD exhibited significantly higher NEFA level
than CF1-CD throughout the experiment, except females
at the 5th week. Furthermore, there was a significant rise
in NEFA level in females of CF1-CD at the 25th and 30th
weeks as well as females of DF1-CD at the 5th week,
compared to their male counterparts (Fig. 3).
Members of DF1-CD showed significantly higher hep-
atic TGs content compared to CF1-CD from the 15th
week to the 30th week, except females at the 15th week.
Also, all members of DF1-HCD showed a significant rise
in their hepatic TGs content from the 10th week com-
pared to CF1-CD, and from the 15th week compared to
CF1-HCD, till the end of the experiment (Fig. 4).
CF1-HCD group showed significantly elevated muscu-
lar TGs content from the 10th week till the 30th week
compared to CF1-CD, except males at week 25, and
females at weeks 20 and 30. Also, DF1-CD group exhib-
ited a significant high muscular TGs content at the 15th
week till the 30th week compared to CF1-CD. All mem-
bers of DF1-HCD, except females at the 5th week, had
the same pattern throughout the study period. Males of
DF1-CD at the 25th and 30th weeks as well as females at
the 30th week had a significant higher muscular TGs con-
tent than CF1-HCD. All members of DF1-HCD (except
females at the 5th week) had a significant elevated muscu-
lar TGs content compared to CF1-HCD. Furthermore,
females of DF1-CD (except at the 30th week) and DF1-
HCD had significantly lower muscular TGs content than
their male counterparts (Fig. 4, Tables 1 and 2).
All diabetic groups exhibited elevated serum total
cholesterol level compared to CF1-CD throughout the 3
time points. CF1-HCD group had higher serum total
cholesterol level than CF1-CD only at the 30th week.
Furthermore, males of DF1-CD showed higher serum
total cholesterol level compared to CF1-HCD at the 5th
and 30th weeks. All DF1-HCD members had a significant
increase in their serum total cholesterol level compared
to CF1-HCD throughout the follow-up time points,
except the females at week 30, which did not show this
significant difference (Fig. 2).Regarding serum high-density lipoprotein-cholesterol
(HDL-C) levels, all diabetic groups, except females of
DF1-CD at the 5th and 30th weeks, showed lower HDL-
C levels than CF1-CD group. Also, all males of the
diabetic groups at the 3 tome points as well as females
of DF1-HCD at the 30th week showed significantly lower
HDL-C level compared to CF1-HCD. Furthermore,
members of CF1-HCD at the 30th week exhibited a
significant lower HDL-C than CF1-CD group. Females
had higher HDL-C level throughout the experiments;
however, only CF1-CD at the 5th week as well as diabetic
groups at the 30th week showed a significant sex differ-
ence (Fig. 2).
All diabetic groups at the 15th and 30th weeks, except
females of DF1-CD at the 30th week, showed high levels
of low-density lipoprotein-cholesterol levels (LDL-C)
compared to CF1-CD group. Moreover, all members of
DF1-HCD at the 15th week as well as males of diabetic
groups at the 30th week showed a significant elevated
LDL-C level than CF1-HCD group. Significant sex
difference appeared only in DF1-HCD at the 15th week
and in DF1-CD at the 30th week (Fig. 2).
Serum levels of cytokines
Females had significant higher serum adiponectin levels
than their male counterparts in all study groups (except
DF1-CD at the 10th week and DF1-HCD at the 25th
week) throughout the study period. Males of CF1-HCD
and DF1-CD showed significantly lower serum adipo-
nectin levels than CF1-CD from the 20th week to the
30th week. Males of DF1-HCD (from weeks 10 till 30)
and females of the same group (at the 25th and 30th
weeks) exhibited significantly lower serum adiponectin
levels than CF1-CD. Males of DF1-CD (at weeks 25 and
30), males of DF1-HCD (at all study period except the
5th week) and females of DF1-HCD (at weeks 25 and 30)
had a significantly lower adiponectin levels compared to
CF1-HCD (Fig. 5).
Females had significant elevated serum leptin levels
than their male counterparts in all study groups
throughout the study period. Throughout the study,
males of CF1-HCD (except the 5th week), all members
of DF1-CD (except females at week 5 and 30) and all
members of DF1-HCD (except females at week 5) had a
significantly lower leptin levels compared to CF1-CD.
Males of DF1-CD (except at weeks 5 and 10) had signifi-
cantly lower leptin levels than CF1-HCD, while females
of the same group at weeks 5 and 10 had significantly
higher leptin levels compared to CF1-HCD. Females of
DF1-HCD (except at week 5) showed significantly higher
leptin levels compared to CF1-HCD (Fig. 5).
Females had significant higher serum TNF-α levels
than their male counterparts in all study groups (except
CF1-HCD and DF1-CD at the 5th week) throughout the
Fig. 2 Lipid profile parameters for all study groups. Data are presented
as mean ± SD (n = 10). Abbreviations denote: CF1-CD; F1 offspring of
control mothers under CD, CF1-HCD; F1 offspring of control mothers
under HCD, DF1-CD; F1 offspring of diabetic mothers under CD, and
DF1-HCD; F1 offspring of diabetic mothers under HCD. *Significant
different compared to the CF1-CD group by ANOVA (p < 0.05).
#Significant different compared to the CF1-CD group by ANOVA
(p < 0.05). @Significant different from the males of the same group at
the same age by t test (p < 0.05)
Tawfik et al. Journal of Animal Science and Technology  (2017) 59:1 Page 7 of 11study period. All members of DF1-HCD and all males of
DF1-CD and CF1-HCD had significantly higher serum
TNF-α levels compared to CF1-CD. Also, females of CF1-
HCD (at weeks 15, 20, 25) and females of DF1-CD (at
weeks 10 and 15) showed significantly higher serum TNF-
α levels compared to CF1-CD. Moreover, all males of
DF1-CD at every time point and females of the same
group at week 10 exhibited significantly higher serum
TNF-α levels compared to CF1-HCD. All males of DF1-
HCD at every time point and females of the same group
at weeks 10,25 and 30 exhibited significantly higher serum
TNF-α levels compared to CF1-HCD (Fig. 5, and Table 3).
Discussion
According to the hypothesis of fetal origin of adult
diseases, the intrauterine environment may have a
critical influence on long-term health and disease of the
offspring. Therefore, intrauterine milieu may alter the
metabolic status of the fetus, driving an insulin resist-
ance state and facilitates the development of type 2
diabetes mellitus and metabolic syndrome in the adult
life, especially following a postnatal obesogenic environ-
ment [12]. In support of this idea, our findings indicate
that F1 offspring of diabetic mothers exhibited impaired
glucose homeostasis, dyslipidemia, insulin resistance, and
dysregulated adipokines production, paving the way for
the development of diabetes and its complications, espe-
cially when they encounter diabetogenic environment.
Dyslipidemia is one of the major risk factors for the
development of cardiovascular diseases in the context of
diabetes mellitus. The cardinal features of diabetic
dyslipidemia are: a high plasma TGs level, low HDL-C
level and elevated level of small dense LDL-C particles.
These lipid changes are attributed to the increased
NEFA flux secondary to adipose tissue insulin resistance
[13]. The increase in NEFA flux instigates insulin resist-
ance in liver and muscle through direct or indirect (via
triglyceride deposits) generation of metabolites, interfer-
ing with insulin signalling pathway [14]. Moreover,
NEFA play a crucial role in the development of β-cell
dysfunction [15].
Hyperinsulinemia has a pivotal role in the develop-
ment of hepatosteatosis and hepatic insulin resistance
[16]. Consistently, offspring of diabetic mothers showed
Fig. 4 Data are presented as mean ± SD (n = 10). Abbreviations denote: CF1-CD; F1 offspring of control mothers under control diet, CF1-HCD; F1
offspring of control mothers under HCD, DF1-CD; F1 offspring of diabetic mothers under control diet, and DF1-HCD; F1 offspring of diabetic
mothers under HCD. (*) Significant Different from CF1-CD by ANOVA (p < 0.05), (#) significant Different from CF-HCD by ANOVA (p < 0.05), and
(@) significant different from male at each age by t-test (p < 0.05)
Fig. 3 Data are presented as mean ± SD (n = 10). Abbreviations denote: CF1-CD; F1 offspring of control mothers under control diet, CF1-HCD; F1
offspring of control mothers under HCD, DF1-CD; F1 offspring of diabetic mothers under control diet, and DF1-HCD; F1 offspring of diabetic
mothers under HCD. (*) Significant different from CF1-CD by ANOVA (p < 0.05), (#) significant different from CF-HCD by ANOVA (p < 0.05), and
(@) significant different from male at each age by t-test (p < 0.05)
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Fig. 5 Data are presented as mean ± SD (n = 10). Abbreviations denote: CF1-CD; F1 offspring of control mothers under control diet, CF1-HCD; F1
offspring of control mothers under HCD, DF1-CD; F1 offspring of diabetic mothers under control diet, and DF1-HCD; F1 offspring of diabetic
mothers under HCD. (*) Significant different from CF1-CD by ANOVA (p < 0.05), (#) significant different from CF-HCD by ANOVA (p < 0.05), and
(@) significant different from male at each age by t-test (p < 0.05)
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cles. However, the elevated NEFA level only appeared in
offspring of diabetic mothers that was fed high caloric
diet, suggesting the role of the postnatal environment in
the development of metabolic disturbances in the off-
spring. In human, young, normoglycemic and insulin-
resistant offspring of parents with type 2 diabetes showed
impaired muscular signaling with enhanced intramyocel-
lular lipid content [17].
Our data indicates that in-utero maternal diabetes is
sufficient for alteration the adipocytokines production in
the offspring during their adult life, and the diabetogenic
environment exaggerates this effect. Offspring of diabetic
mothers showed low levels of adiponectin, high levels of
leptin, and elevated levels of TNF-α. Assessment of the
serum adiponectin in diabetic patients is useful for
evaluating the metabolic status and for determining the
risk of cardiovascular diseases [18].
It has been shown that inflammatory markers are
increased in the offspring of type 2 diabetic patients
[19–21]. Also, there is a strong association between
markers of inflammatory activity and endothelial dysfunc-
tion, the trigger for cardiovascular diseases [4]. Interest-
ingly, increased inflammatory mediators may predict the
future development of obesity and diabetes. The elevated
concentrations of TNF-α and interleukin-6 (IL-6)
might interfere with insulin action by suppressing in-
sulin signal transduction [22]. Therefore, inactivation
of TNF-α by infliximab ameliorates diabetic nephrop-
athy in streptozotocin-induced diabetic mice [23].
Conclusion
In conclusion, dysregulated adipocytokines production
could be a possible mechanism for the transgenerational
transmittance of diabetes, especially when the offspring
encounter diabetogenic environment. Furthermore, serum
adipokines level could be a powerful tool to predict the
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